ConductScience.org, home

Paper7513616

Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination.

Cross AH and 2 others. Cell Immunol, 1993. Cited by 89 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Papers, record 7513616. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7513616

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination.
PubMed
Journal
Cell Immunol
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
89
iCite
Relative citation ratio, by iCite
1.91
iCite
Revised in PubMed
2012-11-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cross AHA H
2Tuohy VKV K
3Raine CSC S

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Encephalomyelitis, Autoimmune, ExperimentalMajor topic
Myelin ProteinsMajor topic
Amino Acid Sequence
Animals
Chronic Disease
Female
Immunotherapy, Adoptive
Lymphocyte Activation
Mice
Molecular Sequence Data
Myelin Basic Protein
Myelin Proteolipid Protein
Peptide Fragments
Recurrence

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
NS 08952NINDS NIH HHSUnited StatesR01NS008952PubMed and NIHNIH RePORTER
NS 11920NINDS NIH HHSUnited StatesP01NS011920PubMed and NIHNIH RePORTER
NS 29095NINDS NIH HHSUnited StatesR29NS029095PubMed and NIHNIH RePORTER
P50NS011920NIHNIH RePORTER

Download CSV of grants

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.

PMIDTitleJournalYearIn PapersSource
27423965Amelioration of EAE by a cryptic epitope of myelin oligodendrocyte glycoprotein.J Neuroimmunol2016https://conductscience.org/library/papers/27423965PubMed
25267971Progression of relapsing-remitting demyelinating disease does not require increased TCR affinity or epitope spread.J Immunol2014https://conductscience.org/library/papers/25267971PubMed
18674593Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.Neuroscience2009https://conductscience.org/library/papers/18674593PubMed
9836383Oral tolerance and the treatment of rheumatoid arthritis.Springer Semin Immunopathol1998https://conductscience.org/library/papers/9836383PubMed
9120012Diversity and plasticity of self recognition during the development of multiple sclerosis.J Clin Invest1997https://conductscience.org/library/papers/9120012PubMed
9104817Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis.J Exp Med1997https://conductscience.org/library/papers/9104817PubMed
8994863Epitope spreading.Curr Opin Immunol1996https://conductscience.org/library/papers/8994863PubMed
8833909Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.J Clin Invest1996https://conductscience.org/library/papers/8833909PubMed
8675668Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.J Clin Invest1995https://conductscience.org/library/papers/8675668PubMed
8666934
A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
J Exp Med1996https://conductscience.org/library/papers/8666934PubMed
8022835Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8022835PubMed
7971958Oral tolerance.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/7971958PubMed
7540658Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.J Exp Med1995https://conductscience.org/library/papers/7540658PubMed
7539461Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.J Clin Invest1995https://conductscience.org/library/papers/7539461PubMed
7528355Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review.Neurochem Res1994https://conductscience.org/library/papers/7528355PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MBP4155PubTator's text mininghttps://conductscience.org/library/genes/4155

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7513616

GET https://conductscience.org/api/papers/v1/7513616/authors